Bovie Medical Names Jack McCarthy Chief Commercialization Officer
Business Wire - Mon Mar 31, 3:39PM CDT
Bovie Medical (NYSE MKT:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced today the appointment of Jack McCarthy, 47, as Chief Commercialization Officer.
Bovie Medical Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Mon Mar 31, 3:01PM CDT
--Fourth Quarter 2013 Highlights
Bovie Medical Corporation Fourth Quarter and Full Year 2013 Earnings Conference Call to be Held on Monday, March 31, 2014
Business Wire - Thu Mar 20, 10:22AM CDT
Bovie Medical Corporation (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that it will issue financial results and corporate developments for the fourth quarter and full year 2013, following the close of market on Monday, March 31, 2014.
Bovie Medical Corporation Closes Strategic $7.0M Equity Investment Through Great Point Partners
Marketwire - Mon Dec 16, 6:30AM CST
Bovie Medical Corporation (the "Company"
Global Electrosurgical Devices Market 2012-2016 with Covidien plc, CONMED Corp. and Erbe Elektromedizin GmbH Dominating
M2 - Thu Nov 14, 10:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/xwzgq3/global) has announced the addition of the "Global Electrosurgical Devices Market 2012-2016" report to their offering. The analysts forecast the Global Electrosurgical Devices market to grow at a CAGR of 5.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for minimally invasive surgery. The Global Electrosurgical Devices market has also been witnessing rapid advancements in technology. However, the risk of side effects could pose a challenge to the growth of this market. The key vendors dominating this market space are Covidien plc, CONMED Corp., and Erbe Elektromedizin GmbH. The other vendors mentioned in the report are adeor Medical AG, Ambu A/S, ArthroCare Corp., B. Braun Melsungen AG, Boston Scientific Corp., Bovie Medical Corp., BOWA- electronic GmbH & Co. KG, Ethicon Inc., KLS Martin Group GmbH & Co. KG, Olympus Corp., Symmetry Medical Inc., and Utah Medical Products Inc. Commenting on the report, an analyst from the team said: One of the upcoming trends in the Global Electrosurgical Devices market is the rapid advancements in technology using electrosurgery devices. The biggest concern today is safety of patient and staff. Improved technologies have been developed that can cut and coagulate tissue faster and more successfully, with minimal thermal and electrical spread, and reduced interference with intra-operative monitoring equipment. Moreover, for safety purposes, medical device manufacturers have developed advanced energy modalities that consist of argon beam coagulation to stop bleeding, lasers for specific hemostatic partition, ultrasound for selective tissue aspiration, saline enriched coagulation, ferromagnetic technology for defined hemostatic splitting up with negligible collateral damage, without passing current through the tissue. In addition, there is a rise in commercialization of application specific electrosurgery units or specialty generators designed to be used with particular accessories for a specific treatment modality. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. According to the report, one of the major growth factors driving the market is increasing demand for minimally invasive surgery worldwide. Minimally invasive surgery offers numerous benefits to patients and surgeons including faster recovery, fewer post-surgery infections, less pain, reduced visible marks, bleeding control, and enhanced accuracy. For more information visit http://www.researchandmarkets.com/research/xwzgq3/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Bovie Medical Reports Results for Three and Nine Months Ended September 30, 2013
Marketwire - Thu Nov 14, 10:01AM CST
Bovie Medical Corporation (the "Company"
Bovie Medical Corporation Reports on J-Plasma(R) Presentation at American Urologic Gynecology Conference on October 16, 2013
Marketwire - Thu Oct 24, 11:56AM CDT
Bovie Medical Corporation (the "Company"
Bovie Medical Corporation Announces J-Plasma(R) Accepted for Presentation at the Prestigious 42nd AAGL Annual Global Congress on Minimally Invasive Gynecology
Marketwire - Tue Aug 27, 7:02AM CDT
Bovie Medical Corporation (the "Company"
Bovie Medical Corporation Reports Results for Three and Six-Months Ended June 30, 2013
Marketwire - Wed Aug 14, 7:30AM CDT
Bovie Medical Corporation (the "Company"
Bovie Medical Corporation's Annual Meeting of Shareholders Sees Royce T. Adkins, M.D., Report Favorably on J-Plasma(R)
Marketwire - Tue Jul 23, 7:02AM CDT
Bovie Medical Corporation (the "Company"
Royce T. Adkins, M.D., Reports Favorably On J-Plasma(R) At Bovie Medical Corporation's Annual Meeting of Shareholders
ACCESSWIRE - Fri Jul 19, 7:35AM CDT
MELVILLE, NY, July 19, 2013 -(eTeligis via ACCESSWIRE)- Bovie Medical Corporation (the "Company"
All Other Basic Inorganic Chemical Manufacturing Industry 2013 Q2 Edition: Industry's Revenue for 2012 was $27.6 Billion USD
M2 - Thu May 30, 11:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggvl66/all_other_basic) has announced the addition of Supplier Relations US, LLC's new report "All Other Basic Inorganic Chemical Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]" to their offering. This 2013 report's 184 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through March 2013. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2017. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report. The industry's revenue for the year 2012 was reported at $27.6 billion USD, w
Bovie Medical Corporation Reports First Quarter Results and New Progress on J-Plasma(R)
Marketwire - Wed May 15, 7:30AM CDT
Bovie Medical Corporation (the "Company"
Bovie Medical Corporation Announces Fiscal Year 2012 Financial Results
PR Newswire - Mon Apr 01, 7:30AM CDT
Bovie Medical Corporation (the "Company"
Bovie Medical Corp. Continues To Receive Positive Responses For Its J-Plasma(TM) Technology
PR Newswire - Mon Mar 25, 7:30AM CDT
Bovie Medical Corporation (NYSE AMEX: BVX) (the "Company"
New Zealand Surgical Equipment Market Outlook to 2018
M2 - Fri Mar 22, 6:43AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s7c44b/new_zealand) has announced the addition of the "New Zealand Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures" report to their offering. GlobalData's new report, New Zealand Surgical Equipment Market Outlook to 2018- Electrosurgical Devices, Hand Instruments and Surgical Sutures provides key market data on the New Zealand Surgical Equipment market. The report provides value (USD million), volume (units) and average price (USD) data for each segment within three market categories - Electrosurgical Devices, Hand Instruments and Surgical Sutures. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available. Scope - Market size and company share data